Hypertrophic Obstructive Cardiomyopathy: Clinical Trials

1 trial for Hypertrophic Obstructive Cardiomyopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Hypertrophic Obstructive Cardiomyopathy: new trials by email Literature Review of Hypertrophic Obstructive Cardiomyopathy trials Research Report on Hypertrophic Obstructive Cardiomyopathy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mobilization of Endothelial Progenitor Cells and Aspirin
Aspirin - Hypertrophic Obstructive Cardiomyopathy
Phase 3TerminatedOttawa Heart Institute Research Corporation62016-05-012023-01-17

Narrower conditions

Cardiomyopathy, Hypertrophic (1)

Broader conditions

Aortic Stenosis, Subvalvular (1)  ·  Aortic Valve Disease (1)  ·  Aortic Valve Stenosis (1)  ·  Cardiomyopathies (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Heart Valve Diseases (1)

Interventions

Aspirin (1)

Sponsors

Ottawa Heart Institute Research Corporation (1)

Countries

Canada (1)

Top investigators

Aun-Yeong Chong, MD, MRCP (1)

Results publications

PMID 16539843, PMID 20659762, PMID 23713888